Executive Summary
124 corporate events are scheduled for August 7, 2026: 121 financial results and 3 board meetings. Companies on the calendar include Aarti Pharmalabs Limited, Advait Energy Transitions Limited, Afcons Infrastructure Limited, Akshar Spintex Limited, Alankit Limited, Anuh Pharma Limited and 116 others.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior India Quarterly Results BSE NSE Announcements digest from August 06, 2026.
Scheduled Events (124)
Companies with corporate events on the calendar for this day.
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
Afcons Infrastructure Limited has informed the Exchange about Board Meeting to be held on 07-August-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2026 and Fund Raising
To consider and approve the Unaudited financial results for the period ended Jun 30, 2026 and other business matters.
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and to take on record the unaudited Standalone & Consolidated financial results (provisional) for the quarter ended 30th June, 2026.
To consider and approve the Unaudited Standalone and Consolidated financial results for the quarter ended Jun 30, 2026.
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026 and Recommend a Final Dividend for FY 2025-26 on equity share.
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter ended 30th June, 2026
To consider and approve unaudited standalone and consolidated financial results for the period ended Jun 30, 2026
Blue Coast Hotels Limited has informed the Exchange about Board Meeting to be held on 07-Aug-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2026.
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the unaudited financial results for the quarter ended Jun 30, 2026
CARE Ratings Limited has informed the Exchange about Board Meeting to be held on August 07, 2026 to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
Board Meeting Intimation to Consider and Approve the Unaudited Financial Results for the Quarter ended 30th June, 2026.
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
To consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2026 and dividend
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the Un-Audited Standalone and Consolidated Financial Results, for the period ended June 30, 2026, Consider and recommend final dividend, if any, Consider and decide day, date, time & venue of 18th Annual General Meeting (AGM), Approve the Board Report, Corporate Governance Report, Management Discussion and Analysis Report for the financial year ended March 31, 2026 and other business matters of the Company.
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2026 and dividend
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026 and Fund Raising
To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on Jun 30, 2026
To consider and approve the unaudited Standalone and Consolidated financial results for the quarter ending Jun 30, 2026
To consider and approve the unaudited financial results for the period ended June 30, 2026 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the Unaudited financial results for the quarter ended June 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters.
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the Unaudited Financial Results for the Quarter ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the following matters:1. Unaudited Financial Results for the first quarter ended June 30, 2026 along with the Limited Review Report by the Statutory Auditors of the Company.2. The allotment of Equity Shares pursuant to the exercise of vested Employee Stock Options by the eligible employee(s) under the MIRC Electronics Employee Stock Option Plan, 2023.
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
Intimation of Board Meeting
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve unaudited financial results for the quarter ended on June 30, 2026, amendment of Praxis- Employee stock option plan-2024, evaluate proposals of fund raise and AGM related matters
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the standalone & consolidated un-audited financial results for the quarter ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
To consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended June 30, 2026
To consider and approve the financial results for the period ended Jun 30, 2026
Source: company filings and exchange event calendars. Times shown in local market time when published.
Get daily alerts with full AI analysis of all 124 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Quarterly Results BSE NSE Announcements
August 05, 2026
India Quarterly Results BSE NSE Announcements — August 05, 2026
August 04, 2026
India Quarterly Results BSE NSE Announcements — August 04, 2026
August 03, 2026
India Quarterly Results BSE NSE Announcements — August 03, 2026
August 02, 2026
India Quarterly Results BSE NSE Announcements — August 02, 2026
🇮🇳 More from India
View all →August 07, 2026
India Pre-Market Regulatory Roundup — August 07, 2026
India Pre-Market Regulatory Roundup
August 07, 2026
India Upcoming Corporate Actions BSE NSE — August 07, 2026
India Upcoming Corporate Actions BSE NSE
August 06, 2026
India Pre-Market Regulatory Roundup — August 06, 2026
India Pre-Market Regulatory Roundup
August 06, 2026
India Upcoming Corporate Actions BSE NSE — August 06, 2026
India Upcoming Corporate Actions BSE NSE